Soni Medicare [SML] vs Indraprastha Medical [INDRAMEDCO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Soni Medicare Ltd. wins in 6 metrics, Indraprastha Medical Corporation Ltd. wins in 12 metrics, with 0 ties. Indraprastha Medical Corporation Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Soni Medicare Ltd. | Indraprastha Medical Corporation Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 115.75 | 20.08 | Indraprastha Medical Corporation Ltd. |
| Price-to-Book Ratio | 340.87 | 5.57 | Indraprastha Medical Corporation Ltd. |
| Debt-to-Equity Ratio | 12,636.41 | 4.76 | Indraprastha Medical Corporation Ltd. |
| PEG Ratio | 0.16 | -5.81 | Soni Medicare Ltd. |
| EV/EBITDA | -47.04 | 12.10 | Indraprastha Medical Corporation Ltd. |
| Profit Margin (TTM) | -7.45% | 12.60% | Indraprastha Medical Corporation Ltd. |
| Operating Margin (TTM) | -13.97% | 13.64% | Indraprastha Medical Corporation Ltd. |
| EBITDA Margin (TTM) | N/A | 13.64% | N/A |
| Return on Equity | -14.35% | 26.98% | Indraprastha Medical Corporation Ltd. |
| Return on Assets (TTM) | -0.84% | 18.90% | Indraprastha Medical Corporation Ltd. |
| Free Cash Flow (TTM) | $8.11M | $1.20B | Indraprastha Medical Corporation Ltd. |
| Dividend Yield | N/A | 0.95% | N/A |
| 1-Year Return | 22.36% | -13.77% | Soni Medicare Ltd. |
| Price-to-Sales Ratio (TTM) | 1.12 | 2.53 | Soni Medicare Ltd. |
| Enterprise Value | $396.03M | $32.43B | Indraprastha Medical Corporation Ltd. |
| EV/Revenue Ratio | 1.48 | 2.23 | Soni Medicare Ltd. |
| Gross Profit Margin (TTM) | 73.93% | 37.00% | Soni Medicare Ltd. |
| Revenue per Share (TTM) | $63 | $158 | Indraprastha Medical Corporation Ltd. |
| Earnings per Share (Diluted) | $-4.68 | $19.94 | Indraprastha Medical Corporation Ltd. |
| Beta (Stock Volatility) | -0.70 | 0.58 | Soni Medicare Ltd. |
Soni Medicare Ltd. vs Indraprastha Medical Corporation Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Soni Medicare Ltd. | 0.00% | 0.00% | 3.96% | 50.39% | -27.51% | -27.51% |
| Indraprastha Medical Corporation Ltd. | 6.84% | 1.09% | -9.03% | -4.19% | -24.80% | -16.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Soni Medicare Ltd. | 22.36% | 301.10% | 118.89% | 128.13% | 355.97% | 355.97% |
| Indraprastha Medical Corporation Ltd. | -13.77% | 314.55% | 315.68% | 619.68% | 949.24% | 1,109.38% |
Performance & Financial Health Analysis: Soni Medicare Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹299.48M | ₹37.31B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 12 | 399,153 |
| 90 Day Avg. Volume | 158 | 289,583 |
| Last Close | ₹73.00 | ₹401.45 |
| 52 Week Range | ₹43.82 - ₹114.15 | ₹342.00 - ₹640.85 |
| % from 52W High | -36.05% | -37.36% |
| All-Time High | ₹114.15 (Oct 30, 2025) | ₹640.85 (Nov 06, 2025) |
| % from All-Time High | -36.05% | -37.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.27% | 0.14% |
| Quarterly Earnings Growth | -0.29% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | 0.13% |
| Operating Margin (TTM) | -0.14% | 0.14% |
| Return on Equity (TTM) | -0.14% | 0.27% |
| Debt to Equity (MRQ) | 12,636.41 | 4.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹0.21 | ₹71.88 |
| Cash per Share (MRQ) | ₹3.47 | ₹50.31 |
| Operating Cash Flow (TTM) | ₹-10,735,087 | ₹1.78B |
| Levered Free Cash Flow (TTM) | ₹-1,863,768 | ₹1.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.95% |
| Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Soni Medicare Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | SML (Apr 24, 2026) | INDRAMEDCO (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 115.75 | 20.08 |
| Forward P/E | N/A | 18.63 |
| PEG Ratio | 0.16 | -5.81 |
| Price to Sales (TTM) | 1.12 | 2.53 |
| Price to Book (MRQ) | 340.87 | 5.57 |
| Market Capitalization | ||
| Market Capitalization | ₹299.48M | ₹37.31B |
| Enterprise Value | ₹396.03M | ₹32.43B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.48 | 2.23 |
| Enterprise to EBITDA | -47.04 | 12.10 |
| Risk & Other Metrics | ||
| Beta | -0.70 | 0.58 |
| Book Value per Share (MRQ) | ₹0.21 | ₹71.88 |
Financial Statements Comparison: Soni Medicare Ltd. vs Indraprastha Medical Corporation Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SML (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Revenue/Sales | 298.38M | 13.07B |
| Cost of Goods Sold | 84.88M | 8.53B |
| COGS % of Revenue | 28.4% | 65.3% |
| Gross Profit | 213.51M | 4.54B |
| Gross Margin | 71.6% | 34.7% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 11.34M | 2.10B |
| Operating Margin | 3.8% | 16.1% |
| EBITDA | 19.65M | 2.64B |
| EBITDA Margin | 6.6% | 20.2% |
| Pre-Tax Income | -2.22M | 2.16B |
| Pre-Tax Income % of Revenue | -0.7% | 16.6% |
| Income Tax | -353,039 | 553.30M |
| Income Tax % of Revenue | -0.1% | 4.2% |
| Net Income (Profit) | -1.86M | 1.61B |
| Profit Margin | -0.6% | 12.3% |
Balance Sheet & Liquidity Metrics
| Metric | SML (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Cash & Equivalents | 20.10M | 614.80M |
| Total Current Assets | 137.75M | 4.31B |
| Total Current Assets % of Revenue | 46.2% | 33.0% |
| Total Current Liabilities | 99.90M | 1.79B |
| Total Current Liabilities % of Revenue | 33.5% | 13.7% |
| Long-Term Debt | 94.12M | 305.40M |
| Long-Term Debt % of Revenue | 31.5% | 2.3% |
| Total Shareholders Equity | 12.98M | 5.97B |
| Retained Earnings | -29.75M | 4.75B |
| Retained Earnings % of Revenue | -10.0% | 36.4% |
| Property, Plant & Equipment | 96.87M | 2.60B |
Cash Flow Statement Comparison
| Metric | SML (2025) | INDRAMEDCO (2025) |
|---|---|---|
| Operating Cash Flow | -10.74M | 1.78B |
| Operating Cash Flow % of Revenue | -3.6% | 13.6% |
| Capital Expenditures | -6.60M | -363.30M |
| Free Cash Flow | 8.11M | 1.20B |
| FCF Margin | 2.7% | 9.2% |
| Debt Repayment | 0 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.26M | 91.67M |
| Float Shares | 735,707 | 41.01M |
| % Held by Insiders | 81.66% | 55.41% |
| % Held by Institutions | 0.00% | 0.57% |
| % Held by Public | 18.34% | 44.02% |
Dividend Analysis & Yield Comparison: Soni Medicare Ltd. vs Indraprastha Medical Corporation Ltd.
| Metric | SML | INDRAMEDCO |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 0.95% |
| 3-Year Avg Annual Dividend | N/A | ₹4.00 |
| 3-Year Avg Dividend Yield | N/A | 1.26% |
| 3-Year Total Dividends | N/A | ₹12.00 |
| Ex-Dividend Date | N/A | Sep 18, 2025 |